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Abstract
Introduction The aim of this study was to report a long-term follow-up of patients treated with autologous matrix-induced 
chondrogenesis (AMIC) for full-thickness chondral and osteochondral defects of the femoral condyle or patella combined 
with the correction of lower limb malalignment or patellar tracking if indicated.
Methods Thirty-three patients (thirty-four knees) were treated surgically for chondral and osteochondral cartilage defects of 
the knee joint. Regarding the origin of the lesion, patients were divided into three groups. Chondral lesions were observed in 
the patella (cP group) in fifteen patients, whereas eight patients demonstrated a femoral condylar location (cF group). Eleven 
patients presented with osteochondritis dissecans of the femur (ocF group). Associated procedures involving realignment of 
the patella, osteotomy around the knee, or cancellous bone grafting were performed when necessary. The mean size of the 
lesions was 2.8 ± 1.6  cm2, and the mean patient age was 37.1 ± 11.9 years. To evaluate the clinical outcomes, the Lysholm 
score and the VAS pain score were imposed, as well as the reoperation rate.
Results After an average of 9.3 ± 1 years, follow-up was completed in 79% of the patients. Two patients from the cohort 
received a total knee prosthesis. The primary outcome measures (Lysolm and VAS pain) at 9-year follow-up were 85 ± 13 
for the Lysholm score and 1.9 ± 1.6 for the VAS score in the entire analyzed population. Compared to the preoperative values 
(Lysholm 56 ± 19, VAS 5.8 ± 2.4) and the 2-year results (Lysholm 85 ± 16, VAS 2.0 ± 2.1), there was significant improvement 
in the first 2 years after intervention and a stable course in the long-term observation. The same was observed in the cP and 
ocF subgroups, whereas patients of the cF group showed even further improvement.
Conclusions AMIC showed durable results in aligned knees. The favorable outcome was maintained after an average of 
9 years when malalignment of the lower limb and patellar maltracking were corrected. Such data are particularly encourag-
ing for young adult patients who may benefit from a procedure that circumvents early arthroplasty.
Keywords Autologous matrix-induced chondrogenesis · AMIC · Bone marrow stimulation · HTO · Patellofemoral 
maltracking
Introduction
Articular cartilage in the adult is a type of highly special-
ized connective tissue that is built to last a lifetime. The 
half-life of type II collagen is estimated to be approximately 
117 years [1], which is an underlying reason why its regen-
erative potential is limited. Mature chondrocytes, imbed-
ded in a healthy structural framework of collagen, have low 
anabolic and proliferative activities and therefore a limited 
need for vascular support or nerve supply. Because of this, 
there is very limited healing potential for cartilage defects in 
cases of damage. The consequence of this inadequate repair 
leads to irreversible cartilage degeneration and causes osteo-
arthritis [2].
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Therefore, partial-thickness cartilage tears will not heal 
once formed, whereas full-thickness osteochondral defects 
will partially fill with fibrocartilage scar tissue. The concept 
of using the intrinsic healing potential of the full-thickness 
cartilage lesion was first described by Pridie in 1959 and was 
further developed by Steadman to the use of microfracture 
(MFx), and this concept is based on the fact that mesenchy-
mal stem cells (MSCs) arising from subchondral bone mar-
row will migrate toward the defect [3, 4]. A further evolution 
of MFx has been described by Behrens et al., who published 
their results on the use of autologous matrix-induced chon-
drogenesis (AMIC) [5]. In this technique, the blood clot that 
forms in the defect after MFx is stabilized by a collagen 
I/III membrane (Chondro-Gide®, Geistlich Pharma AG, 
Switzerland), providing an additional framework and more 
stability against shear forces in joint motion [6]. Since its 
introduction, AMIC has shown good short- and mid-term 
results [7, 8] that are comparable to those of MFx [9]. More 
recent data, based on a randomized controlled clinical trial, 
have analyzed the 5-year results after AMIC procedures in 
the knee versus microfracture alone [10]. These data showed 
significant clinical improvement for the first 2 years in both 
the microfracture and AMIC groups. Thereafter, a progres-
sive and significant degradation in the functional score was 
observed in the MFx group by 5 years, while all functional 
parameters remained stable for at least 5 years of follow-up 
in the AMIC group. Additionally, stable results after 5 years 
have recently been published for the AMIC technique in the 
knee [11] and the hip, as well as for talar cartilage repair 
[12, 13].
Currently, it is well accepted that in the case of com-
partmental overload, a lower limb alignment correction is 
mandatory in combination with cartilage repair for medial or 
lateral compartment cartilage defects [14, 15]. Realignment 
of any extensor mechanism maltracking is also a needed 
concomitant procedure in patellofemoral joint lesions [16, 
17] to optimize biomechanics in the knee and influence clini-
cal outcome.
The purpose of this 10-year study is to retrospectively 
analyze the clinical outcomes of AMIC procedures. The 
hypothesis is that the promising results of the AMIC pro-
cedure will remain good, especially when alignment is 
maintained.
Materials and methods
All patients treated with an AMIC procedure in the HFR-
Fribourg District Hospital (Switzerland) for full-thickness 
cartilage tears of the knee between 2003 and 2006 were 
retrospectively reviewed. All patient data have been fully 
anonymized and collected according to institutional board 
recommendations.
The inclusion criteria were as follows: full documenta-
tion of the clinical examination, presence of preoperative 
Lysholm score, and VAS pain score; full documentation of 
the defect localization and size; and a complete postopera-
tive follow-up at 2 years that included the Lysolm score and 
VAS pain score. All patients with complete documentation 
of the above were included to the final follow-up.
Thirty-three patients (34 knees) who met the inclusion 
criteria were identified. Patients completed the scores either 
during a standard visit at our clinic or where contacted by 
phone. According to the etiology and location of the chon-
dral lesion, the patients were divided into three groups. All 
concomitant procedures performed in patients who received 
AMIC were also reported. The first group consisted of fif-
teen patients with a chondral lesion of the patella (cP group). 
The second group presents eight patients with pure chondral 
defects in one of the femoral condyles (cF group). The third 
group includes ten patients (eleven knees, one bilateral case) 
with osteochondral lesions of the femur (ocF group). All 
lesions were in a chronic status; there were no acute trau-
matic lesions. There was no difference between the base-
line criteria of all patients within the 3 groups (i.e., age and 
defect size), except for the localization and associated treat-
ment procedures. The baseline demographics of all groups 
are shown in Table 1.
Indication
As the indication for AMIC cartilage repair is highly related 
to axial alignment, the senior author performed a thorough 
analysis of any patellofemoral maltracking or any lower leg 
axial deviation. One-leg standing films (coronal, 45° coro-
nal, lateral, and patellar axial) were routinely performed 
as well as long-leg views. In addition, MRI or CT scans 
were obtained when necessary. If malalignment of the lower 
extremity was identified (varus or valgus deviation), the 
decision of leg axis correction was made and planned as a 
concomitant surgery during the AMIC procedure. At that 
time, any deformity above 5° of varus or 3° of valgus was 
considered as a malalignment and therefore corrected. The 
amount of correction aimed to reach 3° of valgus in varus 
knees and a neutral alignment for valgus knees. Patellofemo-
ral maltracking when associated with recurrent patellar dis-
location or pathological TTTG (< 20 mm) led to realignment 
procedure essentially by a transfer of the tibial tubercle, a 
lateral release, and a reinforcement of the vastus medialis 
muscle. Because of this policy, knees during the performed 
cartilage procedures were not subjected to any mechanical 
overload.
All of the patients in the cP group received realignment 
of the extensor mechanism during the same surgery. In 
the cF group, axial corrective osteotomy was performed 
in seven patients (coronal tibial correction in six patients 
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and sagittal femoral correction in one patient) in conjunc-
tion with cartilage repair. In the ocF group, five coronal 
osteotomies (four tibial valgizations and one femoral vari-
zation) were associated with the AMIC procedure. Among 
these ocF patients, nine received a cancellous bone graft 
as well because the sub chondral bone stock was consid-
ered to be insufficient after debridement (Fig. 1).
Surgical procedure
First, arthroscopy was performed to confirm the location 
and size of the defect as well as the feasibility of the AMIC 
procedure. This first step was followed by lower limb oste-
otomy when indicated.
Then, an open procedure that consisted of debridement 
and excision of the loosened cartilage fragment followed 
by Pridie drilling of the sclerotic bone and coverage of the 
defect with a collagen I/III membrane (Chondro-Gide®, 
Table 1  Baseline data of all 33 
patients (34 knees)
Subgroups ocF: cP: chondral lesion of the patella; cF: chondral femoral lesion; osteochondral femoral 
lesion
All cP cF ocF
Number 33 (34) 15 8 10 (11)
Age (years) 37.1 ± 11.9 40.2 ± 12.9 38.0 ± 9.9 32.2 ± 11.0
Sex 22m/11 f 8m/7f 7m/1f 7m/3f
Localisation
 Patella 15 15 – –
 Medial femoral condyle 14 – 7 7
 Lateral femoral condyle 4 – 1 3
 Femoral trochlea central 1 – – 1
Outerbridge
 2°–3° 2 1 3 0
 3° 5 0 5 0
 4° 3 5 18 10
 Unknown 5 2 8 1
Defect size  (cm2) 2.8 ± 1.6 2.6 ± 0.9 2.9 ± 2.3 3.0 ± 1.6
Concomitant treatment
Tibial osteotomy 11 – 7 4
Femoral osteotomy 2 1 – 1
Patella realignment 1 15 1 –
Cancellous bone graft 9 – – 9
Meniscal repair 5 3 – 2
Ligament repair 1 – 1 -
Fig. 1  Summary of concomitant alignment procedures in 33 patients (34 knees)
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Geistlich Pharma AG, Switzerland) was performed under 
a tourniquet. In the first six patients, the membrane was 
sutured to the surrounding healthy cartilage only. For the 
subsequent patients, the membrane was sutured and glued 
with  Tissucol® (Baxter, Unterschleissheim, Germany). For 
the chondral defects close to the cartilage margins, the mem-
brane has been sutured to the adjacent periosteum. At the 
end of the procedure, the tourniquet was released, and the 
correct filling of the defect by blood clotting was confirmed 
(Fig. 2).
Outcome measures
The primary endpoints were the clinical Lysholm and VAS 
scores reported by the patients. All patients completed a 
questionnaire for the Lysholm score [18] and the VAS score 
for the assessment of preoperative pain, and they also com-
pleted these questionnaires at the 2- and 10-year follow-up 
assessments. The Lysholm score was used as the primary 
outcome score because the Lysholm score is reliable and 
valid in this setting [18], and it has been previously used by 
several authors for similar indications [8, 16, 18–21]. The 
secondary endpoint was revision surgery or reoperation dur-
ing the 10-year follow-up period.
Statistical analysis
Qualitative variables were described by absolute and relative 
frequencies of their categories. This analysis was performed 
per group and for the pooled data. Distributions of numeric 
variables were summarized by the number of non-missing 
values, means, standard deviations, extreme values, and 
three quartiles. This analysis was assessed per group and 
for the pooled data. The study groups were compared by 
approximate Kruskal–Wallis tests regarding numeric vari-
ables and by exact Fisher–Freeman–Halton tests in the case 
of categorical variables. Within a study group and pooled 
over all study groups, pairwise exact two-sided Wilcoxon 
signed-rank tests were used to assess significance over time. 
The presented p values are Bonferroni corrected, i.e., mul-
tiplied by three because there were three tests (0 vs 2, 0 vs 
10, and 2 vs 10). All tests were performed in an exploratory 
manner with a 5% level of significance.
Fig. 2  a–c Intraoperative images of an AMIC procedure for a retropatellar chondral defect. a Initial defect; b Pridie drilled surface; c defect cov-
ered with a sutured collagen I/III membrane
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All statistical analyses were performed using the statistics 
software R version 3.3.2 along with package “coin” for exact 
rank tests [22].
As this was a retrospective, non-comparative study, power 
calculation was not performed. The sample size was deter-
mined by the number of cases that were recruited. This pro-
cedure has already been described in a respective paragraph 
of the STROBE explanatory article [23].
Results
We included 33 patients (34 knees). Seven patients were lost 
to follow-up.. The follow-up rate of the cohort was there-
fore 26/33 patients (79%). From the remaining 26 patients, 
two underwent revision surgery: a total knee prosthesis for 
degenerative changes was implemented 9 and 10 years after 
the AMIC procedure. The first patient belonged to the cF 
group, and the second patient belonged to the cP group. 
As clinical scores of these patients are not referable to the 
AMIC or initial procedure, these patients were excluded 
from further interpretation (two drop out). The final follow-
up was completed in 24 patients (25 knees). The mean time 
to follow-up was 9.3 ± 1.0 years. Details of patient flow are 
shown in Fig. 3. 
At the 9-year follow-up, the primary outcomes (Lysholm 
score and VAS pain score) for all recruited patients were 
85 ± 13 for the Lysholm score and 1.9 ± 1.6 for the VAS 
score. The values that were measured preoperatively and 
at the 2-year follow-up showed that there was a significant 
improvement in the first 2 years. After that, no significant 
differences were observed between the 2- and 9-year results 
for both the Lysholm and VAS scores (Table 2, Fig. 4) in the 
analyzed population.
In the subgroups, the same, stable course over time 
was observed in the chondral patellar group (cP) and the 
osteochondral femoral group (ocF). A different course was 
observed in the chondral femoral group (cF): in contrast to 
Allocaon
Final follow-up
Enrollment 33 paents (34 knees)
ocF group
10 paents (11knees) 
cP group
15 paents 
7 paents (8 knees)
Ø FU 9.1 years
Drop out 0
7 paents
Ø FU 9.9 years
Drop out 1 (TKA)
12 paents
Ø FU 9.3 years
Drop out 1 (TKA)
cF group
8 paents 
Lost to follow-up = 3Lost to follow-up = 1Lost to follow-up = 3
Fig. 3  CONSORT flow diagram showing the progression of all 33 
patients enrolled in this study. Subgroups: cP: chondral patella group; 
cF: chondral femoral group; ocF: osteochondral femoral group; All 
patients completed the 2-year follow-up. There were 7 patients lost to 
follow-up between 2- and 9-year control
Table 2  Lysholm score and VAS pain scale for all patients and subgroups
Data presented as mean values ± standard deviation
cP chondral lesion of the patella, cF chondral femoral lesion, ocF osteochondral femoral lesion
Group Score Pre-OP 2-year follow up 9-year follow-up p value
2 years vs. pre
p value
2 years vs. 
9 years
p value
9 years vs. pre
All Lysholm 56 ± 19 85 ± 16 85 ± 13  < 0.001 n.s  < 0.001
VAS 5.8 ± 2.4 2.0 ± 2.1 1.9 ± 1.6  < 0.001 n.s  < 0.001
cP Lysholm 63 ± 17 87 ± 14 85 ± 14  < 0.001 n.s 0.005
VAS 5.4 ± 2.1 1.9 ± 1.8 2.3 ± 2.1  < 0.001 n.s 0.003
cF Lysholm 57 ± 24 74 ± 19 81 ± 16 n.s n.s 0.044
VAS 5.8 ± 3.3 3.4 ± 3.2 1.6 ± 1.2 n.s n.s 0.013
ocF Lysholm 47 ± 15 89 ± 14 87 ± 9 n.s n.s 0.008
VAS 6.4 ± 2.1 1.2 ± 1.0 1.5 ± 1.1  < 0.001 n.s 0.008
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the other two groups, we found no significant improvement 
in the first two postoperative years but improvement in the 
following years compared to the preoperative values, with 
the best outcome found for this group 9 years after surgery 
(Table 2, Fig. 4).
The global survival rate in the long-term follow-up in 
this cohort is expressed by the Kaplan–Meier curve (Fig. 5). 
Among 26 patients who reached the 10-year follow-up, two 
patients (7%) received a total knee prosthesis for sympto-
matic knee arthritis at 9 and 10 years after the initial AMIC 
procedure.
Discussion
The most important finding of the present study was that the 
clinical results of autologous matrix-induced chondrogenesis 
remained stable up to 10 years after surgery. The presented 
data show the results of AMIC combined with concomitant 
realignment procedures whenever needed according to pre-
operative radiological data. Compared to the clinical out-
comes 2 years after surgery, the scores show at least similar 
results. In the group treated for femoral chondral lesions, 
there was an even further improvement at 9 years compared 
to the 2-year results. To the best of our knowledge, this is 
the first study investigating long-term results of up to 9 years 
after an AMIC procedure for the knee joint.
These results confirm those of previous investiga-
tions regarding AMIC after 2 and 5 years [8, 10, 24] that 
30
40
50
60
70
80
90
100
RAEY9RAEY2ENILESAB
LYSOLM SCORE
Lysolm ALL Lysolm cF group Lysolm cP group Lysolm ocF group
n.s.
n.s.
p<0.05
to baseline 
n.s.
0
1
2
3
4
5
6
7
8
9
10
RAEY 9RAEY 2ENILESAB
VAS PAIN
VAS ALL VAS cF group VAS cP Group VAS ocF group
p<0.05
to baseline 
n.s.
n.s.
n.s.
Fig. 4  Mean Lysholm score and VAS pain scale pre-operatively and 2 and 9 years after AMIC
Fig. 5  Kaplan–Meier survival curve with total knee arthroplasty 
(TKA) as the endpoint
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reported no progressive deterioration, as was observed 
in the MFx procedure. A newer report from Schiavone 
Panni et al. also showed promising results with significant 
clinical and functional improvements for up to 7 years in 
patients with cartilage defects (> 2  cm2) of the knee treated 
with an AMIC procedure [11]. The presented long-term 
results support the treatment algorithm proposed by sev-
eral authors suggesting that for medium-sized defects (2–4 
 cm2), cartilage lesions should be treated by “enhanced 
microfracture” or “microfracture plus”, which includes 
protection of the superclot by a covering membrane, cor-
responding to the AMIC technique [25–27].
These data confirm the hypothesis that clinical benefits 
may be more robust in AMIC-treated patients. Compared 
with the results found for patients treated with MFx only, 
the results of MFx “failures” characterized by revision 
surgery with either ACI or TKA have been reported in up 
to 54% of patients 9.8 years after initial procedure [28]. 
Additionally, a mean value has been established among 
several MFx studies that reported failures of over 20% 
5–10 years after surgery [29, 30]; these presented results 
seem favorable compared to these data since the revision 
rate was 7% at 9 years.
Comparing AMIC with autologous chondrocyte trans-
plantation (ACI), a cell-based technic with widespread use 
for cartilage defects > 2 cm2 [31], AMIC has the advantage 
of being a simple, safe and cost-effective one-step procedure 
[24]. Regarding long-term results of ACI, there is a durable 
benefit for the patient in the long-term follow-up [21, 32]. 
The reported results are comparable to those reported for 
AMIC [33, 34] but with the burden of the need for a second 
intervention. Further randomized controlled long-term trials 
are needed to compare these technics.
Even if these results are promising, some limitations must 
be considered. First, the heterogeneous patient population 
with respect to the localization and cause of the underly-
ing lesion, as well as the concomitant procedures performed 
during the AMIC procedure, must be recognized. The con-
comitant surgeries during AMIC may confound the results. 
Therefore, it is not correct to assign the results to the car-
tilage treatment alone but to the whole treatment strategy 
decided individually for each patient. The data reported here 
also reflect a concrete and empiric use of a technique with 
therapeutic paradigms. At least, and except in some specific 
traumatic lesions, cartilage defects result from impairments 
in balance within the knee joint with consecutive focal artic-
ular overload. Without adequate treatment of the underlying 
pathology, there will be no durable improvement of articular 
knee function. Therefore, outcomes of knee joint articular 
defects cannot rely only on cartilage therapy because these 
defects are only one part of the mechanical, biological, and 
metabolic aspects of knee degeneration. To minimize the 
bias caused by this fact, we divided the patients into three 
groups according to the location of the defect, leading to the 
previously described concomitant procedures.
A common cause of femoro-tibial overload is malalign-
ment of the lower extremity. In our population, eight out of 
nine patients in the cF group received high tibial osteotomy 
(HTO). Whether HTO, with or without a concomitant car-
tilage procedure, can induce or improve cartilage healing 
is a topic of ongoing discussion. While Kahlenberg et al. 
with the use of a systematic review showed that HTO and 
cartilage restoration procedures provided effective and reli-
able improvements in knee function [19], a recent system-
atic review published by Filardo et al. concluded that there 
was no evidence available to support the effectiveness of 
combined cartilage treatment [35]. Bode et al. compared 19 
patients treated with ACI and HTO and 24 patients treated 
with HTO alone for chondral defects of the knee with cor-
onal malalignment of less than 5°. Even with this minor 
degree of malalignment, they were able to show a lower 
rate of reintervention in the combined group compared to 
the isolated procedure up to 6 years after surgery [14]. A 
report from Ferruzzi et al. with a follow-up of 11 years com-
pared HTO alone and HTO with ACI as well as HTO with 
MFx in 56 patients [36]. At the time of the final follow-up, 
improvements in the clinical and radiographic results were 
obtained in all patients. HTO associated with ACI showed 
significantly higher scores than HTO combined with MFx. 
Interestingly, as already reported for MFx as an isolated pro-
cedure, the scores of HTO with MFx showed higher rates 
of deterioration and progression of osteoarthritis over time. 
In the group reported here of AMIC associated with HTO, 
stable clinical results over a period of 10 years after surgery 
were observed. This confirms the hypothesis that the AMIC 
procedure combined with the realignment procedure con-
tributes to favorable and stable clinical results.
Regarding axial alignment of lower extremity, there are 
several reports supporting the correction of patellofemoral 
maltracking in combination with cartilage repair. Gigante 
et  al. investigated twelve patients with an Outerbridge 
III° and IV° lesion and patella maltracking defined by a 
TT-TG > 20 mm. They showed improvements in all clini-
cal scores (Kujala, Tegner, Lysholm, and Cincinnati scores) 
36 months after MACI and realignment procedures [16]. A 
report from Gillogly et al. described 27 patients undergoing 
an ACI procedure combined with tibial tubercle transfer. 
Their results showed a significant improvement in symp-
toms and function in patients with isolated symptomatic 
patellar chondral defects up to 7 years after surgery [17]. 
In the present evaluation, all 15 patients with a chondral 
cartilage lesion (cP group) received a combined procedure, 
including AMIC and patellar realignment surgery. Similar 
to the results found in the other groups, a significant func-
tional improvement was measured within the first 2 years 
and remained stable up to 10 years after surgery.
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In the ocF group, nine out of eleven patients received 
a cancellous bone graft. As published by Johnson et al., 
autologous cancellous bone grafting is known to be helpful 
in large defects, especially to restore the convex geometry 
of the articular surface [37]. Additionally, an autologous 
cancellous bone graft contains numerous pluripotent pro-
genitor cells, which are also part of the cartilage resto-
ration process in the AMIC procedure. Homburg et al. 
confirmed good mid-term results of AMIC in combina-
tion with cancellous bone grafting [38]. The short- and 
long-term results in this group are similar to those of pure 
chondral defects.
Further limitations need to be mentioned. First, this was 
a mono-center study; thus, it could be argued that external 
validity is limited. We are aware that no single study is 
capable of providing full external validity because it has 
been reported that large variation exists across and within 
countries in terms of orthopedic treatments [39]. Second, 
the study has a retrospective design and suffers from meth-
odological weaknesses common in this design. Third, the 
data are based on patient-reported outcome measures and 
revision rates, but these have been shown to be important 
assessments for measuring patient satisfaction.
The presented long-term data emphasize that a com-
bined strategy, meaning correct recognition of physiologi-
cal rather than non-physiological knee function, may be 
advantageously instead of performing only a cartilage-
stimulating procedure, such as the AMIC or any other 
cartilage repair procedure alone. Regarding the cartilage 
repair technique used, AMIC showed durable results in 
aligned knees compared to the reported results of simple 
microfracture and thus should be preferred in this context.
Conclusion
The present data confirm the long-lasting clinical benefit 
of AMIC for focal cartilage lesions as long as the overall 
alignment of the lower limb and patellofemoral tracking 
are maintained. In our opinion, it is crucial to correct bio-
mechanics of the knee in the same operation as this is the 
underlying problem leading to the cartilage lesion.
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